ストックスクリーナーアプリを入手
13.02
2.98%
-0.40
前日終値:
$13.42
開ける：
$13.62
24時間の取引高:
1.83M
Relative Volume:
0.89
時価総額：
$1.52B
収益：
$59.61M
当期純損益:
$-262.14M
株価収益率:
-3.3214
EPS:
-3.92
ネットキャッシュフロー:
$-247.49M
1週間 パフォーマンス:
+1.88%
1か月 パフォーマンス:
-0.46%
6か月 パフォーマンス:
+56.12%
1年 パフォーマンス:
+40.45%
1日の値動き範囲:
$12.75
$13.94
1週間の範囲:
$12.32
$13.94
52週間の値動き範囲:
$6.99
$16.20
Arcutis Biotherapeutics Inc Stock (ARQT) Company Profile
名前
Arcutis Biotherapeutics Inc
セクター
電話
805-418-5006
住所
3027 TOWNSGATE ROAD, WESTLAKE VILLAGE, CA
ARQT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ARQT
Arcutis Biotherapeutics Inc
|
13.02 | 1.52B | 59.61M | -262.14M | -247.49M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Arcutis Biotherapeutics Inc Stock (ARQT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-30 | 開始されました | H.C. Wainwright | Buy |
| 2024-08-28 | 開始されました | Jefferies | Buy |
| 2024-01-03 | アップグレード | Mizuho | Neutral → Buy |
| 2023-10-26 | ダウングレード | Mizuho | Buy → Neutral |
| 2023-10-13 | ダウングレード | Goldman | Buy → Neutral |
| 2022-09-07 | 開始されました | Needham | Buy |
| 2022-03-17 | 開始されました | Goldman | Buy |
| 2021-06-30 | 開始されました | Mizuho | Buy |
| 2021-05-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-09 | アップグレード | Goldman | Neutral → Buy |
| 2020-10-08 | 開始されました | Truist | Buy |
| 2020-02-25 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-02-25 | 開始されました | Cowen | Outperform |
| 2020-02-25 | 開始されました | Goldman | Neutral |
| 2020-02-25 | 開始されました | Guggenheim | Buy |
すべてを表示
Arcutis Biotherapeutics Inc (ARQT) 最新ニュース
(ARQT) Proactive Strategies - Stock Traders Daily
Arcutis Biotherapeutics (ARQT) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Arcutis to Present at the TD Cowen 45th Annual Health Care Conference - The Manila Times
Dermatology Leader Arcutis Takes Center Stage at Major Healthcare Conference - StockTitan
Wall Street Analysts Think Arcutis Biotherapeutics (ARQT) Could Surge 51.64%: Read This Before Placing a Bet - MSN
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Down 9.5%Should You Sell? - MarketBeat
High Growth Tech Stocks To Watch In February 2025 - Yahoo Finance
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Up 20%Time to Buy? - MarketBeat
Fishman Jay A Ltd. MI Acquires 118,400 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) - MarketBeat
Arcutis Biotherapeutics (ARQT) Surges 15.9%: Is This an Indication of Further Gains? - MSN
Health Care Roundup: Market Talk - MSN
Arcutis Biotherapeutics' (ARQT) Buy Rating Reaffirmed at Guggenheim - MarketBeat
Brokerages Set Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Target Price at $16.60 - MarketBeat
Arcutis Biotherapeutics jumps amid takeover speculation - MSN
Here's Why Arcutis Biotherapeutics (ARQT) Could be Great Choice for a Bottom Fisher - MSN
Arcutis Biotherapeutics executive sells shares worth $153,873 By Investing.com - Investing.com Nigeria
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Down 7.7%Here's What Happened - MarketBeat
Chronic Plaque Psoriasis Market Expected to rise, 2034 | - openPR
Trend Tracker for (ARQT) - Stock Traders Daily
4 Analysts Have This To Say About Arcutis Biotherapeutics - Benzinga
Chronic Plaque Psoriasis Treatment Market Size Report 2034 | - openPR
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Insider Masaru Matsuda Sells 8,338 Shares - MarketBeat
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Director Howard G. Welgus Sells 10,000 Shares - MarketBeat
Arcutis Biotherapeutics exec sells $27,597 in stock - MSN
Arcutis Biotherapeutics' senior VP Matsuda sells $105,892 in stock - MSN
Have Insiders Sold Arcutis Biotherapeutics Shares Recently? - Simply Wall St
Arcutis director Howard G. Welgus sells $127,100 in common stock - MSN
Jennison Associates LLC Raises Stock Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) - MarketBeat
Arcutis Biotherapeutics executive sells shares worth $153,873 - MSN
Arcutis Soared In 2024, Blazing Trails In Dermatology. Why Its CEO Eyes Bigger Gains. - Yahoo
Arcutis Biotherapeutics CEO Todd Watanabe sells $245,122 in shares - MSN
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Arcutis director Howard G. Welgus sells $127,100 in common stock By Investing.com - Investing.com South Africa
Insider Sell: Howard Welgus Sells 10,000 Shares of Arcutis Bioth - GuruFocus.com
Arcutis Biotherapeutics' senior VP Matsuda sells $105,892 in stock By Investing.com - Investing.com Australia
Arcutis Biotherapeutics exec sells $27,597 in stock By Investing.com - Investing.com Canada
Arcutis Biotherapeutics Inc (ARQT) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):